↓ Skip to main content

The addition of bevacizumab to standard chemotherapy in breast cancer: which patient benefits the most?

Overview of attention for article published in SpringerPlus, May 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
8 Mendeley